Anthony Ford

Dr. Ford brings more than 30 years of neuroscience research, pharmacology, drug discovery and development experience from leading biopharmaceutical companies to his role as co-founder and chief executive officer. He became a co-founder of CuraSen in 2018. Dr Ford also holds senior advisory roles with Site1 Therapeutics and PharmNovo, both developing innovative therapies for pain and related indications, and for New Leaf Venture Partners, where he had previously held the title of venture partner. He is also an advisor to the Stanford SPARK program.

Dr. Ford brings more than 30 years of neuroscience research, pharmacology, drug discovery and development experience from leading biopharmaceutical companies to his role as co-founder and chief executive officer. He became a co-founder of CuraSen in 2018. Dr Ford also holds senior advisory roles with Site1 Therapeutics and PharmNovo, both developing innovative therapies for pain and related indications, and for New Leaf Venture Partners, where he had previously held the title of venture partner. He is also an advisor to the Stanford SPARK program.